Hedgehog pathway agonism: therapeutic potential and small-molecule development.

Area of Science:

• Developmental Biology
• Oncology
• Pharmacology

Background:

• The Hedgehog (Hh) pathway is a critical signaling pathway involved in embryonic development and adult tissue homeostasis.
• Aberrant Hh signaling is implicated in various cancers, leading to extensive research on pathway inhibitors for chemotherapy.
• Conversely, activating the Hh pathway is a potential therapeutic strategy for degenerative and ischemic conditions, though less explored than inhibition.

Purpose of the Study:

• To review recent evidence supporting the therapeutic potential of Hh pathway activators.
• To provide a comprehensive overview of small-molecule Hh agonists.

Main Methods:

• Literature review of recent studies on Hh pathway activators.
• Analysis of small-molecule Hh agonists and their therapeutic applications.

Main Results:

• Recent research highlights the therapeutic promise of Hh pathway activation.
• A growing body of evidence supports the use of small-molecule Hh agonists.

Conclusions:

• Small-molecule Hh agonists represent a promising therapeutic avenue for degenerative and ischemic disorders.
• Further research and development of Hh agonists are warranted for clinical applications.